XRAY
DENTSPLY·NASDAQ
--
--(--)
--
--(--)
5.79 / 10
Netural
Analyst consensus is neutral, with 50% Strong Buy and 50% Neutral ratings from two institutions, reflecting moderate confidence. Fund flow evaluation is positive (7.73/10), yet all size brackets (block, small, medium, large, extra-large) show negative trends, hinting at underlying selling pressure. Together, the analyst and fund flow data support a cautious stance, aligning with the overall neutral recommendation.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-03
InstitutionUBS
Times predicted4
Historical Win Rate75.0%
What is the market sentiment for XRAY?
- XRAY holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.79/10 (Netural).
